Schedule of Consolidated Financial Statements (Details) - USD ($)	3 Months Ended				6 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2024	Dec. 31, 2023
Operating expenses
General and administrative	$ 7,673,022		$ 4,416,716		$ 12,682,863	$ 7,470,713
Research and development	2,919,865		3,569,167		4,952,000	7,183,018
Exploration	234,568		823,425		655,075	2,173,345
Total operating expenses	10,827,455		8,809,308		18,289,938	16,827,076
Net loss before other income (expense)	(13,800,758)		(8,809,308)		(23,603,922)	(16,827,076)
Other income (expense)
Amortization and accretion of financing costs			(1,132,258)			(1,865,154)
Change in fair value of derivative liability			(229,472)			(229,473)
Total other income (expense)	400,252		(1,368,551)		(1,491,153)	(2,242,760)
Net loss attributable to stockholders			(10,177,859)		(25,100,000)	(19,069,836)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	6,330,914	$ 2,420,747	4,261,327	$ 3,369,269
Balance	70,597,046	59,344,596	65,554,556	58,638,365	70,597,046	65,554,556
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and accretion expense					1,904,546	1,865,154
Stock-based compensation					9,502,030	7,691,511
Shares issued for professional services						(448)
Change in fair value of derivative liability			229,472			229,473
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities						2,443,539
Net Cash Used in Operating Activities					(12,815,978)	(7,418,700)
Additional Paid-in Capital [Member]
Other income (expense)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	6,330,914	2,420,747	4,261,327	3,369,269		7,630,596
Balance	310,351,869	285,607,121	245,401,556	228,273,045	310,351,869	245,401,556
Retained Earnings [Member]
Other income (expense)
Net loss attributable to stockholders			(10,177,859)			(19,069,836)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition
Balance	$ (238,423,407)	$ (225,022,901)	(179,896,345)	$ (169,718,486)	$ (238,423,407)	(179,896,345)
Previously Reported [Member]
Operating expenses
General and administrative			4,310,452			7,259,298
Research and development			3,148,873			5,304,187
Exploration			771,523			2,051,305
Total operating expenses			8,230,848			14,614,790
Net loss before other income (expense)			(8,230,848)			(14,614,790)
Other income (expense)
Amortization and accretion of financing costs			(1,053,766)			(1,760,497)
Change in fair value of derivative liability
Total other income (expense)			(1,060,587)			(1,908,630)
Net loss attributable to stockholders			(9,291,435)			(16,523,420)
Balance			66,573,285			66,573,285
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and accretion expense						1,760,497
Stock-based compensation						5,757,908
Shares issued for professional services						(132)
Change in fair value of derivative liability
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities						2,164,539
Net Cash Used in Operating Activities						(7,418,700)
Previously Reported [Member] | Additional Paid-in Capital [Member]
Other income (expense)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition			3,836,466			5,757,908
Balance			243,020,935			243,020,935
Previously Reported [Member] | Retained Earnings [Member]
Other income (expense)
Net loss attributable to stockholders			(9,291,435)			(16,523,420)
Balance			(176,496,995)			(176,496,995)
Revision of Prior Period, Reclassification, Adjustment [Member]
Operating expenses
General and administrative			106,264			211,415
Research and development			420,294			1,878,831
Exploration			51,902			122,040
Total operating expenses			578,460			2,212,286
Net loss before other income (expense)			(578,460)			(2,212,286)
Other income (expense)
Amortization and accretion of financing costs			(78,492)			(104,657)
Change in fair value of derivative liability			(229,472)			(229,473)
Total other income (expense)			(307,965)			(334,130)
Net loss attributable to stockholders			(886,424)			(2,546,416)
Balance			(1,018,729)			(1,018,729)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and accretion expense						104,657
Stock-based compensation						1,933,603
Shares issued for professional services						(316)
Change in fair value of derivative liability			229,472			229,473
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities						279,000
Net Cash Used in Operating Activities
Revision of Prior Period, Reclassification, Adjustment [Member] | Additional Paid-in Capital [Member]
Other income (expense)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition			424,861			1,872,688
Balance			2,380,621			2,380,621
Revision of Prior Period, Reclassification, Adjustment [Member] | Retained Earnings [Member]
Other income (expense)
Net loss attributable to stockholders			(886,424)			(2,546,416)
Balance			$ (3,399,350)			$ (3,399,350)